JP2010532656A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010532656A5 JP2010532656A5 JP2009545705A JP2009545705A JP2010532656A5 JP 2010532656 A5 JP2010532656 A5 JP 2010532656A5 JP 2009545705 A JP2009545705 A JP 2009545705A JP 2009545705 A JP2009545705 A JP 2009545705A JP 2010532656 A5 JP2010532656 A5 JP 2010532656A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- fusion protein
- nucleic acid
- acid molecule
- immunogenic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 102000037865 fusion proteins Human genes 0.000 claims 3
- 230000002163 immunogen Effects 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 102000019034 Chemokines Human genes 0.000 claims 1
- 108010012236 Chemokines Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0700759A GB0700759D0 (en) | 2007-01-15 | 2007-01-15 | Novel fusion protein |
| US91492507P | 2007-04-30 | 2007-04-30 | |
| US91484807P | 2007-04-30 | 2007-04-30 | |
| GB0709707A GB0709707D0 (en) | 2007-05-21 | 2007-05-21 | Novel fusion protein |
| PCT/US2008/050879 WO2008089074A2 (en) | 2007-01-15 | 2008-01-11 | Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010532656A JP2010532656A (ja) | 2010-10-14 |
| JP2010532656A5 true JP2010532656A5 (enExample) | 2011-02-24 |
Family
ID=41111108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009545705A Pending JP2010532656A (ja) | 2007-01-15 | 2008-01-11 | 癌退縮抗原ｎｙ−ｅｓｏ−１およびｌａｇｅ−１を含む融合タンパク質 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2118128B1 (enExample) |
| JP (1) | JP2010532656A (enExample) |
| KR (1) | KR20090122426A (enExample) |
| BR (1) | BRPI0806501A2 (enExample) |
| CA (1) | CA2674458A1 (enExample) |
| DK (1) | DK2118128T3 (enExample) |
| EA (1) | EA016818B1 (enExample) |
| ES (1) | ES2398492T3 (enExample) |
| HR (1) | HRP20130022T1 (enExample) |
| MX (1) | MX2009007572A (enExample) |
| PE (1) | PE20081687A1 (enExample) |
| PL (1) | PL2118128T3 (enExample) |
| SI (1) | SI2118128T1 (enExample) |
| TW (1) | TW200902049A (enExample) |
| WO (1) | WO2008089074A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008308474A (ja) * | 2007-06-18 | 2008-12-25 | Nitto Denko Corp | 抗原ペプチド製剤の調製方法 |
| SG174877A1 (en) | 2009-03-17 | 2011-11-28 | Mdxhealth Sa | Improved detection of gene expression |
| GB0910046D0 (en) | 2009-06-10 | 2009-07-22 | Glaxosmithkline Biolog Sa | Novel compositions |
| AU2012302778B2 (en) * | 2011-08-31 | 2016-11-24 | Mie University | Vaccine preparation for cancer treatment |
| GB201116248D0 (en) | 2011-09-20 | 2011-11-02 | Glaxosmithkline Biolog Sa | Liposome production using isopropanol |
| EP3604271A1 (en) | 2013-06-28 | 2020-02-05 | Auckland Uniservices Limited | Peptides for amino acid and peptide conjugates and conjugation process |
| US20160367651A1 (en) | 2013-10-01 | 2016-12-22 | Mie University | T cell inducing vaccine containing an interepitope sequence that promotes antigen presentation |
| CN107250103A (zh) | 2014-12-23 | 2017-10-13 | 玛格丽特·安妮·布林布尔 | 氨基酸缀合物和肽缀合物以及其用途 |
| AU2017216653B2 (en) | 2016-02-08 | 2021-12-23 | Kyoto University | Pretreatment drug for T cell infusion therapy for immune-checkpoint inhibitor-resistant tumor |
| TW201735952A (zh) | 2016-02-26 | 2017-10-16 | 瑪格蕾特 安 布萊博 | 胺基酸及肽共軛物以及共軛過程 |
| ES3016535T3 (en) * | 2018-11-23 | 2025-05-09 | Strike Pharma Ab | Bi-specific conjugates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06205672A (ja) * | 1992-03-19 | 1994-07-26 | Nippon Zeon Co Ltd | 日本脳炎ウイルス及びｂ型肝炎ウイルスの表面抗原タンパク質の抗原部位を持つキメラタンパク質の製造法、およびそれに用いる組み換えバキュロウイルス |
| US6686147B1 (en) * | 1998-07-15 | 2004-02-03 | Ludwig Institute For Cancer Research | Cancer associated antigens and uses therefor |
| ATE507295T1 (de) * | 2000-03-30 | 2011-05-15 | Dendreon Corp | Zusammensetzungen und verfahren für eine auf dendritischen zellen basierende immuntherapie |
| US20030044813A1 (en) * | 2001-03-30 | 2003-03-06 | Old Lloyd J. | Cancer-testis antigens |
| EP1708741B1 (en) * | 2003-12-24 | 2016-03-30 | Aduro Biotech | Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof |
| GB0409940D0 (en) * | 2004-05-04 | 2004-06-09 | Glaxosmithkline Biolog Sa | Vaccine |
| CN102220357B (zh) * | 2004-11-16 | 2013-12-25 | 克鲁塞尔荷兰公司 | 包含重组病毒载体的多价疫苗 |
| CA2653402A1 (en) * | 2006-05-26 | 2007-12-06 | Glaxosmithkline Biologicals S.A. | Method |
| PT2114993E (pt) * | 2007-01-15 | 2012-11-28 | Glaxosmithkline Biolog Sa | Vacina |
-
2008
- 2008-01-11 ES ES08727588T patent/ES2398492T3/es active Active
- 2008-01-11 WO PCT/US2008/050879 patent/WO2008089074A2/en not_active Ceased
- 2008-01-11 EP EP08727588A patent/EP2118128B1/en not_active Not-in-force
- 2008-01-11 DK DK08727588.9T patent/DK2118128T3/da active
- 2008-01-11 EA EA200900738A patent/EA016818B1/ru not_active IP Right Cessation
- 2008-01-11 KR KR1020097016892A patent/KR20090122426A/ko not_active Ceased
- 2008-01-11 TW TW097101220A patent/TW200902049A/zh unknown
- 2008-01-11 PL PL08727588T patent/PL2118128T3/pl unknown
- 2008-01-11 MX MX2009007572A patent/MX2009007572A/es active IP Right Grant
- 2008-01-11 JP JP2009545705A patent/JP2010532656A/ja active Pending
- 2008-01-11 PE PE2008000128A patent/PE20081687A1/es not_active Application Discontinuation
- 2008-01-11 HR HRP20130022AT patent/HRP20130022T1/hr unknown
- 2008-01-11 BR BRPI0806501-2A2A patent/BRPI0806501A2/pt not_active IP Right Cessation
- 2008-01-11 SI SI200830870T patent/SI2118128T1/sl unknown
- 2008-01-11 CA CA002674458A patent/CA2674458A1/en not_active Abandoned